Hunter Williams
22 May 2026
All links here: https://hunterwilliamshealth.com/links Timestamps: 00:00 Intro 01:00 Why I'm making this video 04:00 The plan: peptides with direct anti-cancer evidence 06:02 AOD-9604 and HGH Frag 176-191 07:42 BPC-157 09:54 DSIP (Delta Sleep Inducing Peptide) 11:08 Epitalon 12:30 Follistatin 344 13:30 GHK-Cu 14:36 Kisspeptin 15:58 KPV 17:18 LL-37 18:46 Melanotan 2 19:58 MOTS-c 21:12 Retatrutide 22:34 Semaglutide 23:40 SS-31 24:38 Thymalin 25:26 Thymosin Alpha-1 27:00 Tirzepatide 27:30 VIP (Vasoactive Intestinal Peptide) 28:06 Bottom line and closing thoughts Description If you spend any time in the peptide social media world, you've heard it. "Peptides cause cancer." It's the easiest way to scare someone off something, and a lot of people do it without ever showing you a single study. So I went and pulled the studies. In this video I walk through every peptide on the popular research peptide list that actually has direct anti-cancer evidence in the published literature. Not theory. Not mechanism guesses. Actual studies in cells, animals, and in some cases, humans. You'll see what the research says about BPC-157, GHK-Cu, Epitalon, KPV, LL-37, Thymosin Alpha-1, MOTS-c, semaglutide, tirzepatide, retatrutide, and a handful more. Some of this evidence is strong. Some is preliminary. I'm honest about both. This is not medical advice and I'm not telling you peptides cure cancer. That's not what the data says and that's not what I'm claiming. What I am saying is that the next time someone hits you with a 60 second clip telling you peptides cause cancer, you'll have something more substantial to weigh it against. All study links below. 📚 Studies Referenced (in order of appearance) AOD-9604 / HGH Frag 176-191 https://pmc.ncbi.nlm.nih.gov/articles/PMC9249349/ BPC-157 https://journals.lww.com/melanomaresearch/citation/2004/08000/bpc_157_inhibits_cell_growth_and_vegf_signalling.50.aspx https://pubmed.ncbi.nlm.nih.gov/29886825/ DSIP https://pubmed.ncbi.nlm.nih.gov/12782416/ Epitalon https://pubmed.ncbi.nlm.nih.gov/14501183/ https://pubmed.ncbi.nlm.nih.gov/12209581/ https://pubmed.ncbi.nlm.nih.gov/12049808/ Follistatin 344 https://pmc.ncbi.nlm.nih.gov/articles/PMC9633376/ GHK-Cu https://neoplasiaresearch.com/index.php/jao/article/view/217 https://www.lidsen.com/journals/genetics/genetics-05-02-128 Kisspeptin https://pubmed.ncbi.nlm.nih.gov/8944003/ https://pubmed.ncbi.nlm.nih.gov/28944853/ KPV https://pmc.ncbi.nlm.nih.gov/articles/PMC4957955/ LL-37 https://pmc.ncbi.nlm.nih.gov/articles/PMC3910284/ https://pmc.ncbi.nlm.nih.gov/articles/PMC3659029/ Melanotan 2 https://pmc.ncbi.nlm.nih.gov/articles/PMC7013727/ MOTS-c https://pmc.ncbi.nlm.nih.gov/articles/PMC11578304/ Retatrutide https://pmc.ncbi.nlm.nih.gov/articles/PMC11908972/ Semaglutide https://pmc.ncbi.nlm.nih.gov/articles/PMC11227080/ https://pubmed.ncbi.nlm.nih.gov/38683947/ https://pmc.ncbi.nlm.nih.gov/articles/PMC12587238/ SS-31 https://pmc.ncbi.nlm.nih.gov/articles/PMC7923037/ Thymalin https://pubmed.ncbi.nlm.nih.gov/6752596/ https://pubmed.ncbi.nlm.nih.gov/29797130/ Thymosin Alpha-1 https://pubmed.ncbi.nlm.nih.gov/8652276/ https://pmc.ncbi.nlm.nih.gov/articles/PMC2748379/ https://pubmed.ncbi.nlm.nih.gov/20194853/ https://pubmed.ncbi.nlm.nih.gov/27900029/ https://pubmed.ncbi.nlm.nih.gov/30063847/ Tirzepatide https://www.biorxiv.org/content/10.1101/2024.01.20.576484v1 https://aacrjournals.org/cancerres/article/84/6_Supplement/2188/738498/Abstract-2188-Tirzepatide-treatment-restores VIP https://pmc.ncbi.nlm.nih.gov/articles/PMC6317926/
0:00 / 0:00